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Enzyme-linked immunosorbent assays (ELISA) of milk and serum samples are a routinely
used method of screening herds for Mycobacterium avium subspecies paratuberculosis
(MAP). Infection with MAP causes granulomatous enteritis of ruminants known as Johne’s
disease (JD). The sensitivity (Se) and specificity (Sp) of MAP ELISAs leads to difficulties in
the identification of both infected and infectious animals. Interference with MAP ELISA Se
and Sp has been reported in MAP seronegative cows following administration of purified
protein derivative (PPD) as part of intradermal testing for bovine tuberculosis (bTB). The
aim of this study is to examine the impact of the single intradermal cervical comparative
test (SICCT) for bTB, on both serum and milk MAP ELISA tests, in a herd containing both
seropositive and seronegative cows pre-SICCT. A secondary objective is to provide appro-
priate timing of JD ELISA tests in relation to the SICCT. A herd of 139 cows were serum and
milk sampled pre- and post-SICCT administration. Prior to SICCT, 6% of the herd tested
seropositive for MAP using milk ELISA, with 8% positive on serum. ID Screen Paratu-
berculosis Indirect Screening Test (ID Vet) was used to screen the herd. Within 14 days
of PPD administration, a significant increase in the prevalence of seropositive cows was
recorded. Identical prevalence’s were recorded with both test matrices (39%). ELISA val-
ues remained significantly higher until day 43 post-SICCT in milk (P =0.850), and day 71 in
serum (P =0.602). If the “new” positives detected post-bTB testing are deemed false pos-
itives due to generation of cross-reacting antibodies by administration of PPD, milk would
appear a more suitable sample for JD ELISA testing within 2 months of SICCT. In summary,
sampling for JD utilizing milk ELISA should be avoided in the 43-day period following PPD
administration, with serum ELISA sampling avoided for an additional 28 days.
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INTRODUCTION
Mycobacterium avium subspecies paratuberculosis (MAP), a mem-
ber of the Mycobacteriacea family, causes chronic granulomatous
enteritis known as Johne’s disease (JD) (1). Clinical JD is character-
ized by diarrhea and progressive cachexia, which ultimately results
in death (2). Uncertainty exists regarding a potential causal link
between MAP and Crohn’s disease in humans (3, 4). The potential
damage to the global dairy industry, should a link between Crohn’s
and MAP be fully substantiated (5), combined with impacts on
animal health, has prompted the establishment of JD control
programs in a number of countries (6–8).
Use of enzyme-linked immunosorbent assays (ELISA) to iden-
tify animals at risk of being infected with MAP is common in
control programs internationally (8, 9), including Ireland (10).
ELISA is favored as a screening test due to its relatively low cost
compared to fecal culture or polymerase chain reaction (PCR)
(11). ELISAs also provide timely results compared to culture meth-
ods (11). The sensitivity (Se) and specificity (Sp) of MAP ELISAs,
however, leads to difficulties in the identification of both infected
and infectious individuals (12).
Mycobacterium bovis, the causative agent of bovine tubercu-
losis (bTB), is an additional pathogenic and definitively zoonotic
(13) member of the Mycobacteriaceae. To reduce the zoonotic risk
posed by bTB, address public/animal health concerns, and limit
trade restrictions, a compulsory national eradication program for
bTB was established in Ireland in 1962 (14). This eradication
program involves ante-mortem testing of all registered bovines
annually using the single intradermal cervical comparative test
(SICCT) and post-mortem carcass inspection. All SICCT positive
animals (reactors) are slaughtered, the herd of origin is restricted,
and additional bTB testing is applied to the herd. The comprehen-
sive nature of the testing program can lead to some animals being
tested up to five times in a single year (15).
The SICCT utilizes intradermal introduction of M. bovis and
M. avium subsp. avium purified protein derivatives (bPPD and
aPPD) at two different sites on the neck to elicit a delayed hypersen-
sitivity response mediated by T cells (16). Comparative measure-
ments at both injection sites, taken 72 h post-PPD administration,
are used to assess infection status (16). Additional ante-mortem
testing methods used internationally for detection of bTB include
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the single intradermal test and the caudal fold test,both less specific
than SICCT (17).
Members of the Mycobacteriaceae family share several anti-
gens, which can lead to diagnostic difficulties due to antibody
cross reaction (18). MAP infection can interfere with specificity
of bTB diagnostics (19), and likewise M. bovis infection can affect
MAP serological tests (20). Varges et al. (21), has also shown inter-
ference by both single and comparative intradermal bTB tests on
MAP sero diagnostics in bTB negative animals. The primary pur-
pose of this current study was to investigate the impact of SICCT
on the prevalence of ELISA positive results (serum and milk) in an
Irish herd containing both MAP ELISA seropositive and seroneg-
ative animals over a period of 6 months. Secondary objectives
included comparing milk and serum ELISA readings and inves-
tigating whether serum samples could be taken at the 72 h bTB
visit without interference from PPD administration.
MATERIALS AND METHODS
STUDY HERD
A 139-cow spring-calving dairy herd (mean-calving date February
19th) was recruited. This herd was depopulated in 1997 following a
confirmed case of bovine spongiform encephalopathy (BSE). The
experimental herd, therefore, consisted of descendants of cows
used to repopulate the farm in 1998 (22). Annual statutory bTB
test results were sourced from 1998 to provide a bTB history for
the herd. Veterinary records were obtained in order to record a JD
history for the herd post-repopulation. Approximately 60% of the
cows were Holstein Friesian (HF), the remaining 40% purebred
Jersey (Je) or Je cross-breeds. The study was licensed by the Irish
Department of Health and Children.
SAMPLE COLLECTION
Milk and serum samples were collected 10 and 13 days prior to
administration of the compulsory annual SICCT herd test in May
2012 (pre-SICCT). The SICCT was administered by the Depart-
ment of Agriculture, Food and the Marine (DAFM) approved
private veterinary practitioner (PVP) responsible for the care of
animals on this farm as is standard practice for the Irish national
bTB eradication scheme. Milk and serum samples were collected
every 14 days (approximately) for 2 months post-SICCT and on a
monthly basis thereafter until the composition of the herd changed
materially due to end of lactation culling (longitudinal data). Sam-
pling dates for serum and milk samples are outlined in Table 1.
A limit of a 7-day interval between serum and milk sampling was
applied in order to consider samples as “matched.” Milk samples
were not available for all cows at every sampling time point which
is reflected as small variations in sample sizes. Additionally, milk
samples were not collected in September 2012 due to an un-related
health issue on farm. Fecal samples were collected on a weekly basis
from consistently ELISA positive cows from 90 days post-SICCT.
These cows were also subjected to a veterinary clinical exam.
Serum and milk samples were tested using a commercial
ISO17025 accredited laboratory (designated laboratory for Irish
voluntary JD control program) using the ID Screen Paratuber-
culosis Indirect Screening Test (ID Vet, Montpellier, France).
The test is an M. phlei absorbed ELISA detecting anti-MAP
IgG. Status of the sample was evaluated by examining the
Table 1 |Timetable of serum and milk samples and dates of SICCT.
Serum
sampling
date
Milk
sampling
date
Days post-PPD
administration
Pre SICCT May 29 May 31
SICCT test day 1 PPD
administration
June 11 0
SICCT day 2 June 14 3
SICCT day 2 – serum
sample only
June 14 3
Post SICCT Match 1 June 20 9
June 25 14
Post SICCT Match 2 July 11 July 11 30
Post SICCT Match 3 July 24 July 24 43
Post SICCT Match 4 August 8 August 8 58
Post SICCT Match 5 August 21 August 21 71
September 5 No sample 99
Post SICCT Match 6 October 1 October 1 112
Post SICCT Match 7 November 1 November 1 143
sample to positive ratio (S/P ratio) calculated using the formula
S/P Ratio= [(ODSample−ODPositive control)÷ (ODPositive control−
ODNegative control)× 100]. Fecal samples were tested by microbial
culture and real-time PCR (rtRT-PCR) using “in-house” method-
ologies developed by Cork Institute of Technology as outlined by
Douarre et al. (23). The target gene was IS900. Primer sequences
for the amplification were 5’-GAAGGGTGTTCGGGGCCGTCG
CTTAGG-3’ and 5’-GGCGTTGAGGTCGATCGCCC ACGTGAC-
3’ (reverse primer).
DATA ANALYSIS
Descriptive analysis, dataset construction, and graphical represen-
tations were completed in Excel (MS Office 2010). Normality of
datasets was examined visually using ladders of power histograms
in Stata (version 12). Additional statistical analyses including chi-
squared test, t -test, box plot construction, Spearman rank correla-
tion, and generalized estimating equations (GEE) were completed
using Stata (version 12).
For the purposes of reporting within-herd MAP prevalence,
ELISA S/P ratio results were interpreted according to manufac-
ture instructions, i.e.,≥70 S/P (serum) and ≥15 S/P (milk) were
categorized as positive, with a single exception. Cows recording
S/P ratios of 60≥ SP< 70 (normally classified as inconclusive),
were also categorized as negative. The prevalence of positive cows
within the herd was plotted vs. trial day. Box plots were constructed
to highlight trends in ELISA S/P % readings pre- and post-SICCT
Longitudinal milk and serum ELISA results were used to create
datasets for statistical analysis. ELISA results were recorded as both
a categorical variable (positive, negative) and a continuous variable
(ELISA S/P readings). Multivariable GEE was used to investigate
differences between pre- and post-SICCT categorical and con-
tinuous variables (dependent variables). Independent variables
included in the models were sampling time point (pre-SICCT,
post-SICCT), breed (Friesian, Jersey), parity (parities 1, 2, 3,≥4),
and date of calving (January, February, March, April). Second level
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interactions between independent variables were examined and
included in the model at P≤ 0.05. For categorical variable analy-
sis, a binomial distribution was assumed and a logit link function
used. For continuous variable analysis, a Gaussian distribution
and an identity link function was used. An exchangeable correla-
tion was applied to both analyses. To investigate the correlation
between milk and serum ELISA results, Spearman correlation (rs)
was performed on categorical data sets.
RESULTS
Results of statutory bTB testing for this farm over the past 8 years
indicate minimal issues with bTB in this herd. Similarly, no bTB
positive reactor was identified following SICCT in 2012. From herd
repopulation in 1998 to commencement of this study, no clinical
case of JD had been diagnosed on the study farm.
Prior to administration of the SICCT, a total of 11 of 139 cows
(7.9%) tested MAP ELISA positive in serum, with 8 of 137 (5.8%)
milk samples testing positive. Following administration of SICCT,
a significant increase in the prevalence of ELISA positives was
recorded on both test matrices (serum P < 0.001; milk P < 0.001).
The highest recorded prevalence of positive results for both serum
and milk samples was 39% (Figure 1). No statistically significant
difference (P = 0.668) was recorded in the prevalence of serum
positive results, pre- and 72 h post-SICCT. Similarly no statisti-
cally significant difference (P = 0. 197) was recorded in S/P ratios
of serum ELISA results pre- and 72 h post-SICCT. Both box plots
and GEE analysis highlight an increase in both serum and milk S/P
ratio readings subsequent to the 72 h sampling (Figures 2 and 3;
Tables 2 and 3, respectively).
Statistically significant differences between pre- and post-
SICCT milk ELISAs were recorded until 43 days post-
administration of PPD, examined as both a continuous and cate-
gorical variable (Table 2). The prevalence of ELISA serum positive
samples was not statistically different from pre-SICCT levels by
day 58, while serum ELISA S/P ratios remained significantly ele-
vated for 71 days post-SICCT (Table 3). It should be noted that
a significant elevation in S/P ratios post-SICCT was again noted
in November (trial day 143) for both milk and serum samples
(Tables 2 and 3). No significant second level interactions were
identified between independent variables.
Spearman correlation analysis of matched serum and milk sam-
ples generated pre SICCT values of rs 0.73. Post SICCT values
ranged from rs 0.55 to 0.79 with the highest levels recorded at post
SICCT test 1 (rs 0.77) and post SICCT test 6 (rs 0.79).
Weekly fecal culture of consistently ELISA positive cows yielded
negative results. A total of 10 animals yielded PCR positive results,
2 of which recorded positive results at each sampling time point.
Veterinary examination did not yield any clinical signs of JD in
these animals.
DISCUSSION
The Irish cattle population is subjected to a comprehensive and
compulsory bTB eradication program, involving administration
of the SICCT on at least an annual basis (15). The purpose of the
current study was to investigate the impact of SICCT (i.e., admin-
istration of bPPD and aPPD) on both the within-herd prevalence
of positive cows and ELISA S/P ratios in an Irish dairy herd. The
results of the current study can provide useful guidance to farmers
and veterinarians on the optimum period to conduct MAP ELISA
testing in regions engaging in comprehensive testing for bTB using
SICCT.
Two international studies, one conducted in Brazil (21), and the
second in the UK (24), have previously shown that tests for bTB
interfere with MAP ELISA diagnostics. Varges et al. (21) reported
ELISA interference occurring between 30 and 90 days post-PPD
administration in bTB and MAP negative cattle. Of the 63 animals
included in that study, 5 were classified as MAP ELISA positive
post-PPD administration using both SICCT and single intrader-
mal tuberculin test. Although the current study highlights a similar
trend, the timescale over which interference is recorded differs.
The increase in the number of animals detected ELISA positive
post-SICCT and subsequent decrease to pre-SICCT prevalence
occurred approximately 2 weeks earlier than the period of inter-
ference outlined by Varges et al. (21). The herd included in the
FIGURE 1 | Percentage (%) of the herd testing positive on Johne’s disease ELISAs (milk and serum) at different trial days, both pre and post the
administration of theTB test. An increased number of positives are identified post TB test administration.
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FIGURE 2 | Box plot identifying differences in serum ELISA S/P ratios at different sampling points, both pre and post the administration of theTB
test. To improve visualization of interquartile ranges, only S/P values <250 are shown.
FIGURE 3 | Box plot identifying differences in milk ELISA S/P ratios at different sampling points, both pre and post the administration of theTB test.
To improve visualization of interquartile ranges, only S/P values <150 shown.
Frontiers in Immunology | Molecular Innate Immunity November 2014 | Volume 5 | Article 564 | 4
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Kennedy et al. TB testing and Johne’s diagnostics
Table 2 | Multivariable GEE analysis of milk ELISA as a continuous (S/P % ELISA readings) and categorical (milk ELISA MAP positive/negative)
dependent variable and independent variables.
Continuous variable Categorical variable
(S/P % ELISA readings) (Milk ELISA MAP positive/negative)
Dependent variable Coefficient P Value significant: 95% C.I. Odds ratio P value 95% C.I. Model
Milk ELISA P<0.05 (P value <0.001)
Independent variable
Time point
June 20 vs. Maya 17.2 <0.001 14.3, 20.2 11.1 <0.001 5.8, 21.0
July 11 vs. May 5.43 <0.001 2.5, 8.4 2.7 0.004 1.4, 5.1
July 24 vs. May 0.29 0.850 −2.7, 3.3 1.1 0.819 0.5, 2.3
August 8 vs. May 0.94 0.537 −2.1, 3.9 1.1 0.831 0.5, 2.3 Sampling time point
August 21 vs. May 0.42 0.784 −2.6, 3.4 1.1 0.829 0.5, 2.3 Parity
Oct vs. May 1.51 0.322 −1.5, 4.5 1.8 0.105 0.9, 3.5 Breed
Nov vs. May 5.65 <0.001 2.6, 8.7 2.5 0.007 1.3, 4.9 Calving date
Parity
1b vs. 2 −11.2 <0.001 −5.4, −17.0 0.3 0.004 1.6, 10.3
2 vs. 3 11.2 0.001 17.5, 4.7 3.3 0.025 0.1, 0.9
2 vs. 4 8.3 0.002 13.5, 3.1 2.5 0.014 0.2, 0.8
aMay is the ELISA sample taken pre SICCT. bParity 1: 1st lactation. No significant interactions identified with other independent variables. C.I., confidence interval.
Coefficient, difference across the sample population. Statistically significant P values highlighted in bold.
Table 3 | Multivariable GEE analysis of serum ELISA as a continuous (S/P % ELISA readings) and categorical (serum ELISA MAP
positive/negative) dependent variable and independent variables.
Continuous variable Categorical variable
(S/P % ELISA readings) (Serum ELISA MAP positive/negative)
Dependent variable Coefficient P value significant: 95% C.I. Odds ratio P value 95% C.I. Model
Serum ELISA P<0.05 (P value <0.001)
Independent variable
Time point
June 14 vs. Maya 4.4 0.197 −2.3, 11.0 1.1 0.668 0.6, 2.1
June 25 vs. May 33.8 <0.001 27.2, 40.5 10.7 <0.001 6.1, 18.8
July 11 vs. May 37.9 <0.001 31.3, 44.6 6.4 <0.001 3.7, 11.1
July 24 vs. May 17.0 <0.001 10.3, 23.7 2.3 0.004 1.3, 3.9
August 8 vs. May 8.7 0.010 2.1, 15.4 1.3 0.392 0.7, 2.3
August 21 vs. May 1.8 0.602 −4.9, 8.4 1.1 0.659 0.5, 1.8
September 5 vs. May 4.0 0.241 −2.7, 10.6 1.0 0.998 0.5, 1.8
October 1 vs. May 6.0 0.080 −0.7, 12.6 0.9 0.641 0.5, 1.6 Sampling time point
November 1 vs. May 11.1 0.001 4.5, 17.7 1.3 0.392 0.7, 2.3 Parity
Parity Breed
1b vs. 2 −29.4 0.006 −50.4, −8.4 0.4 0.053 0.2, 1.0 Calving date
3 vs. 2 −27.6 0.015 −50.0, −5.3 0.3 0.018 0.1, 0.8
4 vs.2 −10.0 0.296 −28.8, 8.8 0.5 0.047 0.2, 1.0
Calving Date
February vs. January −4.0 0.677 −22.9, 14.9 0.3 0.003 0.1, 0.6
March vs. January −24.0 0.066 −49.7, 1.6 0.2 0.002 0.1, 0.5
April vs. January −15.9 0.304 −46.3, 14.5 0.4 0.145 0.1, 1.4
February vs. March 21.7 0.036 1.4, 41.9 1.7 0.241 0.7, 4.4
aMay is the ELISA sample taken pre SICCT test.
bParity 1 – 1st lactation. No significant interactions identified between independent variables. C.I., confidence Interval. Coefficient, difference across the sample
population. Statistically significant P values highlighted in bold.
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current study had a history of recording serum MAP ELISA pos-
itive individuals (within-herd prevalence of 8%). This contrasts
with the Brazilian study where cattle were confirmed MAP fecal
culture negative prior to inclusion in the trial. It is possible, there-
fore, that cows used in the current study had been pre-sensitized
to MAP or additional mycobacterial-related antigens. This being
the case, it would be expected that a more rapid immune response
would result, i.e., a secondary humoral memory response (25).
The longer duration taken to record an IgG response and the lower
proportion of ELISA positive cows identified post-PPD adminis-
tration by Varges et al. (21) may be indicative of a slower primary
immune response (Figure 4). As mentioned previously, Irish cattle
are tested annually using SICCT from the age of 6-weeks, which
may also account for the suggested memory response in Irish cattle
in contrast to their Brazilian counterparts. Additionally, the stud-
ies differed in the ELISA kits used for MAP antibody detection
and used limited sample populations. More extensive studies are,
therefore, required to compare the performance of all commer-
cially available MAP ELISA kits with regard to administration of
both aPPD and bPPD and the need for development of more spe-
cific antigens to improve the specificity and sensitivity of currently
available MAP ELISAs has been clearly highlighted. The inclusion
of a greater number, and diversity, of animals and herds would
also strengthen findings, as would continuation of a study over a
number of years incorporating multiple TB tests.
Varges et al. (21) examined both the single intradermal and
comparative bTB test. Interestingly, cross-reacting antibodies
were detected using both SICCT and single intradermal test,
while administration of aPPD alone did not elicit cross-reacting
antibodies. This would suggest that bPPD may be responsible for
generation of cross-reacting antibodies in the MAP ELISA kits
examined in both studies. This is supported by a study by Olsen
et al. (18), which highlighted reduced MAP ELISA specificity in
animals experimentally infected with bTB. Interestingly, animals
with natural bTB infection did not elicit cross-reacting antibodies
(18), which may again suggest that the intradermal administration
of bPPD, is indeed, the stimulant for generation of cross-reacting
antibodies. Commercially available MAP ELISA kits incorporate
an M. pheli absorption step to increase the specificity of the assay.
Again, Olsen et al. (18) showed this to be an ineffective method of
improving MAP ELISA specificity with regard to bTB. It may be
that while pre-absorption with M. pheli is somewhat successful in
reducing binding of M. avium antibodies, repeated administration
of bPPD negates its effect in preventing non-specific binding. The
potential for a cumulative effect of PPD administration (either
avian or bovine) from multiple bTB tests over a number of years,
therefore, requires thorough investigation to fully characterize the
impact of SICCT on MAP ELISA testing.
In Ireland, herds restricted due to a positive bTB diagnosis
(Directive 64/432/EEC), undergo two repeat tests at a 60-day inter-
val. For herds operating under these restrictions, the results of the
current study highlight that milk samples may be a more suitable
test matrix than serum ELISA to avoid test interference. Similar
to the results obtained by Lombard et al. (26), there was mod-
erate agreement between serum and milk samples. Milk samples,
however, took a shorter interval to return to pre-SICCT levels
FIGURE 4 | Variation in period of influence of SICCT in present study
compared to Varges et al. (21) is shown. V1–V3; Approximate S/P results of
positive cows identified using “in- house” ELISA by Varges et al. (21). Current;
mean ELISA S/P results from entire herd in the present study. Insert; a
schematic of primary and secondary/memory immune response [adapted
from Tizard (25)].
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than serum in the current study. This may reflect the difference
in IgG sub-classes between serum and milk and a lower milk IgG
response (26). The post-SICCT period of elevated milk S/P ratios,
however, may reflect a period of increased IgG production or
IgG secretion from plasma to the mammary gland post-SICCT.
This manifests as increased test sensitivity, stronger correlations
highlighted between milk and serum results post-PPD adminis-
tration. May et al. (24) also recorded significantly higher milk
ELISA readings 4.5 weeks post-PPD administration in a UK herd.
The limited statistical analysis completed by May et al. (24) and use
of only a single testing timepoint post-SICCT presents difficulties
in allowing direct comparisons between both datasets. Addition-
ally, a number of regions in the UK administer the SICCT on one
occasion every 4 years (27), a much longer testing interval than
experienced by Irish herds. The differences highlighted between
Varges et al., (21), May et al., (24) and the current study highlight
the usefulness of examining the impact of SICCT on MAP ELISA
results in multiple jurisdictions in order to more fully elucidate
the impact of bTB testing on MAP diagnosis by ELISA.
It has previously been reported that exposure to environmental
mycobacteria may yield low level protection against M. tuberculo-
sis (28, 29). Hope et al. (30) also reported protection against M.
bovis following exposure to M. avium, and that pre-exposure to
M. avium results in an imprinting of memory against avian anti-
gens onto T-lymphocytes. An amnestic response to environmental
mycobacterial infection combined with continuous boosting of T
cells in response to administration of PPD may, therefore, have the
potential to assist in control of MAP at the animal level. In that
regard, Ireland records a relatively low prevalence of MAP com-
pared to additional milk exporting nations (31). For example, a
total of 232 clinical cases of JD were reported in Ireland from 1995
to 2002 (32), yielding an average annual rate of approximately
0.0005%, given a cattle population of six million cattle (33). Addi-
tionally, Good et al. (34) reported that 20% of Irish herds contain
at least one ELISA positive animal, again a relatively low prevalence
(31). Given that environmental conditions in Ireland are con-
ducive to the growth of mycobacteria (35), and that Irish farmers
engage in high risk management practices with regard to spread of
JD, e.g., widespread pooling of colostrum and milk for calf-feeding
(36) (Kennedy et al. unpublished data), a higher prevalence of clin-
ical cases and MAP ELISA positives might be expected. Another
Irish study (37) recorded no significant associations between MAP
seropositivity and milk production parameters, again contrast-
ing with international studies (38, 39). It is our hypothesis that
repeated annual administration of aPPD and bPPD in Ireland
may induce a protective effect against MAP thereby lessening the
clinical manifestations of MAP infection and resultant production
losses. To more thoroughly investigate this hypothesis, it is neces-
sary to complete in depth investigations as to whether the increase
in antibody levels recorded post-PPD administration in the cur-
rent study equates to an increased T-cell response, which would be
required to achieve such a protective effect (40).
An advantage of the current study was the use of a compact
spring-calving herd. This ensures that all cows examined were at
a similar stage of lactation and physiological status. This allowed
trends in MAP S/P % ratios over the latter half of lactation in
a homogenous population to be examined. In agreement with a
previous study (26), cows in late lactation were more likely to
yield a MAP ELISA positive result using milk samples. The declin-
ing milk yields in late lactation result in a lessening of the dilution
effect on antibody levels thereby increasing antibody concentra-
tions (41). Interestingly, an increase in the prevalence of serum
ELISA positives was also recorded in late lactation. This finding
is in agreement with a Danish study (42). The increase in preva-
lence of serum ELISA positives in the current study corresponds
with housing, which may increase the likelihood of exposure to
mycobacterial antigens by increasing the potential for fecal con-
tact. Nielsen et al. (42) also showed parity 2 and greater to be more
likely to test ELISA positive relative to parity 1 cows, which is also
highlighted in the current study. Parity 3 and 4 animals, however,
were in general less likely to test positive than parity 2. The major-
ity of Irish farmers target compact calving seasons (43) and strict
culling practices are often in place (33). These culling practices
may lead to less ELISA positive animals remaining in the system
post second lactation. Results from this study indicate that age of
animal at sampling and timing of JD ELISA tests relative to stage
of lactation and time of bTB testing are important considerations
when interpreting ELISA results.
CONCLUSION
Administration of PPD as part of the bTB test corresponds to an
increased prevalence of ELISA positives for JD. Diagnostic sam-
pling for JD utilizing milk ELISA should be avoided in the 43-day
period following the bTB test, with serum ELISA sampling not
recommended for an additional 28 days. Based on the increase in
antibody titers in MAP ELISA recorded post-PPD administration,
it is our hypothesis that repeated annual administration of aPPD
and bPPD may induce a protective effect helping to curtail the
clinical manifestations of MAP infection.
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